TL;DR: SynsoryBio is a Y Combinator Winter 2024 startup "If-then" conditional logic for protein drugs, currently active with a team of 2.
"If-then" conditional logic for protein drugs
Last verified:
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Built by LemStudio
Yes. SynsoryBio was funded by Y Combinator in the Winter 2024 batch. "If-then" conditional logic for protein drugs
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
SynsoryBio was part of Y Combinator's Winter 2024 batch.
SynsoryBio has a team of 2 people according to Y Combinator's directory.
SynsoryBio is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…